BSE filing, NSE: SHREEPUSHK. Summary written from the filing by ALFA Finder's alert engine.
Shree Pushkar Chemicals & Fertilisers Ltd: key numbers
- Share price
- ₹542.70
- Market cap
- ₹1,755 Cr
- Revenue (annual)
- ₹976.6 Cr
- Net profit (annual)
- ₹70.10 Cr
- P/E (TTM)
- 24.4×Sector 34.1×
- Promoter holding
- 69.45%+0.09% QoQ
- FII holding
- 0.58%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shree Pushkar Chemicals & Fertilisers Ltd
All →Shree Pushkar Chemicals & Fertilisers Board Meeting Date
Shree Pushkar Chemicals schedules a 2 November 2026 board meeting for September quarter results. Agenda also includes fund raising via preferential issue and authorised capital increase.
Shree Pushkar Chemicals & Fertilisers Other Announcement
The company has filed its quarterly shareholding pattern as mandated by Regulation 31. This is a routine compliance disclosure reflecting the current equity distribution.
Shree Pushkar Chemicals & Fertilisers Annual General Meeting
Shree Pushkar Chemicals & Fertilisers Ltd held its 33rd Annual General Meeting on September 28, 2026. Shareholders approved financial statements and the final dividend.
Shree Pushkar Chemicals & Fertilisers Production Started
Shree Pushkar Chemicals & Fertilisers has commenced commercial production at its new Unit-5 Dyes Segment manufacturing plant located in Ratnagiri, Maharashtra.
Shree Pushkar Chemicals & Fertilisers Other Announcement
Shree Pushkar Chemicals & Fertilisers Ltd has filed its Business Responsibility and Sustainability Report for the financial year 2025-26 with the stock exchanges.
Shree Pushkar Chemicals & Fertilisers Annual General Meeting
Shree Pushkar Chemicals & Fertilisers Limited will hold its 33rd Annual General Meeting on September 28, 2026, via video conferencing to transact seven agenda items.
Other merger & restructuring announcements
All →Quint Digital Merger & Restructuring
Quint Digital's board approved a Rule 10b5-1 trading plan and the incorporation of a wholly owned overseas subsidiary. No investment amount was disclosed.
Hexaware Technologies Merger & Restructuring
Hexaware Technologies approved a slump sale of its step-down subsidiary Tech SMC Square India to Tech SMC Squared (GCC) India, a related-party deal. Consideration is cash, yet to be set by a registered valuer.
- Execution
- Expected completion by 30 June 2027; agreement date stated as 1 December 2026
Emkay Global Financial Services Merger & Restructuring Worth ₹2.75 Cr
Emkay Global agreed to sell its Wealth Management Business to a step-down subsidiary, Emkay Wealth Advisory, for Rs. 2.75 Crore cash. Completion is expected by 26 January 2027.
- Value
- ₹2.75 Cr
- Execution
- Completion expected by 26 January 2027
TVS Holdings Merger & Restructuring
TVS Holdings forwarded TVS Motor's board outcome of October 28, 2026 approving acquisition of Harita ARC and a composite scheme of amalgamation and demerger. The scheme is subject to stock exchange, SEBI, NCLT and shareholder approvals.
Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr
Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.
- Value
- ₹30.00 Cr
- Execution
- Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals
Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr